Osborne Clarke has advised VR Ventures on its investment in CURE Finance as part of the financing round. In addition to VR Ventures, N26 investor Ilavska Vuillermoz and unnamed family offices from Switzerland and Austria as well as several doctors and dentists invested.

CURE Finance sees itself as a neobank for doctors and dentists. The product is to be launched in a few months, initially with an analysis platform for the income and expenditure of their practices and later with a comprehensive financial product with a bank account. The capital from the funding will now finance the product development and launch phase.

The team advising VR Ventures, led by Maximilian Vocke and Robin Eyben (Corporate/VC), consisted of Dana Alpar and Robert Marx (both Corporate/VC), Dr Hans-Christian Woger and Benjamin Schaum (IP/IT) and Dr Robert Rentsch and Kamissa Kruse (Labour Law).

Follow
Corporate communications and press contacts
If you are a journalist and would like comment or background from our legal experts, we can help. Our team will put you in touch with the best person. View a full list of our international press contacts by jurisdiction here.

Connect with one of our experts